Expression of human endogenous retrovirus-K coincides with that of micro-RNA-663 and -638 in germ-cell tumor cells

Anticancer Research

Volumn 32, Issue 11, 2012, Pages 4797-4804

  Kraus, Benjamin ^a   Mönk, Bettina ^a   Sliva, Katja ^a   Schnierle, Barbara S ^a  

^a PAUL EHRLICH INSTITUT   (Germany)

Author keywords

Endogenous retrovirus; Germ cell tumor; microRNA; miR 638; miR 663

Indexed keywords

BETA ACTIN; BETA GALACTOSIDASE; MICRORNA; MICRORNA 638; MICRORNA 663; MICRORNA 720; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CANCER CELL CULTURE; CELL AGING; CELL DENSITY; CELL TRANSFORMATION; CONTROLLED STUDY; ENDOGENOUS RETROVIRUS; GENE EXPRESSION; GERM CELL TUMOR; HUMAN; HUMAN CELL; HUMAN ENDOGENOUS RETROVIRUS K; IN VITRO STUDY; NORTHERN BLOTTING; PRIORITY JOURNAL; RNA ANALYSIS; UPREGULATION; VIRUS EXPRESSION; WESTERN BLOTTING;

BLOTTING, NORTHERN; BLOTTING, WESTERN; ENDOGENOUS RETROVIRUSES; GENE PRODUCTS, ENV; HUMANS; MICRORNAS; NEOPLASMS, GERM CELL AND EMBRYONAL; PROGNOSIS; TRANSCRIPTOME;

EID: 84872659737     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Bannert N and Kurth R: The evolutionary dynamics of human endogenous retroviral families. Annu Rev Genomics Hum Genet 7: 149-173, 2006.
2. Magin C, Lower R and Lower J: cORF and RcRE, the Rev/Rex and RRE/RxRE homologues of the human endogenous retrovirus family HTDV/HERV-K. J Virol 73: 9496-9507, 1999.
3. Lower R, Lower J, Frank H, Harzmann R and Kurth R: Human teratocarcinomas cultured in vitro produce unique retrovirus-like viruses. J Gen Virol 65(Pt 5): 887-898, 1984.
4. Buscher K, Trefzer U, Hofmann M, Sterry W, Kurth R and Denner J: Expression of human endogenous retrovirus K in melanomas and melanoma cell lines. Cancer Res 65: 4172-4180, 2005.
5. Wang-Johanning F, Liu J, Rycaj K, Huang M, Tsai K, Rosen DG, Chen DT, Lu DW, Barnhart KF and Johanning GL: Expression of multiple human endogenous retrovirus surface envelope proteins in ovarian cancer. Int J Cancer 120: 81-90, 2007.
6. Herbst H, Kuhler-Obbarius C, Lauke H, Sauter M, Mueller-Lantzsch N, Harms D and Loning T: Human endogenous retrovirus (HERV)-K transcripts in gonadoblastomas and gonadoblastoma-derived germ cell tumours. Virchows Arch 434:11-15, 1999.
7. Wang-Johanning F, Frost AR, Jian B, Epp L, Lu DW and Johanning GL: Quantitation of HERV-K env gene expression and splicing in human breast cancer. Oncogene 22: 1528-1535, 2003.
8. Ejthadi HD, Martin JH, Junying J, Roden DA, Lahiri M, Warren P, Murray PG and Nelson PN: A novel multiplex RT-PCR system detects human endogenous retrovirus-K in breast cancer. Arch Virol 150: 177-184, 2005.
9. Ishida T, Obata Y, Ohara N, Matsushita H, Sato S, Uenaka A, Saika T, Miyamura T, Chayama K, Nakamura Y, Wada H, Yamashita T, Morishima T, Old LJ and Nakayama E: Identification of the HERV-K gag antigen in prostate cancer by SEREX using autologous patient serum and its immunogenicity. Cancer Immun 8: 15, 2008.
10. Goedert JJ, Sauter ME, Jacobson LP, Vessella RL, Hilgartner MW, Leitman SF, Fraser MC and Mueller-Lantzsch NG: High prevalence of antibodies against HERV-K10 in patients with testicular cancer but not with AIDS. Cancer Epidemiol Biomarkers Prev 8: 293-296, 1999.
11. Lower R: The pathogenic potential of endogenous retroviruses: Facts and fantasies. Trends Microbiol 7: 350-356, 1999.
12. Kleiman A, Senyuta N, Tryakin A, Sauter M, Karseladze A, Tjulandin S, Gurtsevitch V and Mueller-Lantzsch N: HERVK(HML-2) GAG/ENV antibodies as indicator for therapy effect in patients with germ cell tumors. Int J Cancer 110: 459-461, 2004.
13. Hahn S, Ugurel S, Hanschmann KM, Strobel H, Tondera C, Schadendorf D, Lower J and Lower R: Serological response to human endogenous retrovirus K in melanoma patients correlates with survival probability. AIDS Res Hum Retroviruses 24: 717-723, 2008.
14. Galli UM, Sauter M, Lecher B, Maurer S, Herbst H, Roemer K and Mueller-Lantzsch N: Human endogenous retrovirus rec interferes with germ cell development in mice and may cause carcinoma in situ, the predecessor lesion of germ cell tumors. Oncogene 24: 3223-3228, 2005.
15. Boese A, Sauter M, Galli U, Best B, Herbst H, Mayer J, Kremmer E, Roemer K and Mueller-Lantzsch N: Human endogenous retrovirus protein cORF supports cell transformation and associates with the promyelocytic leukemia zinc finger protein. Oncogene 19: 4328-4336, 2000.
16. Denne M, Sauter M, Armbruester V, Licht JD, Roemer K and Mueller-Lantzsch N: Physical and functional interactions of human endogenous retrovirus proteins Np9 and rec with the promyelocytic leukemia zinc finger protein. J Virol 81: 5607-5616, 2007.
17. Buaas FW, Kirsh AL, Sharma M, McLean DJ, Morris JL, Griswold MD, de Rooij DG and Braun RE: Plzf is required in adult male germ cells for stem cell self-renewal. Nat Genet 36:647-652, 2004.
18. Costoya JA, Hobbs RM, Barna M, Cattoretti G, Manova K, Sukhwani M, Orwig KE, Wolgemuth DJ and Pandolfi PP: Essential role of Plzf in maintenance of spermatogonial stem cells. Nat Genet 36: 653-659, 2004.
19. Filippov V, Solovyev V, Filippova M and Gill SS: A novel type of RNase III family proteins in eukaryotes. Gene 245: 213-221, 2000.
20. Bernstein E, Caudy AA, Hammond SM and Hannon GJ: Role for a bidentate ribonuclease in the initiation step of RNA interference. Nature 409: 363-366, 2001.
21. Kim DH, Behlke MA, Rose SD, Chang MS, Choi S and Rossi JJ: Synthetic dsRNA Dicer substrates enhance RNAi potency and efficacy. Nat Biotechnol 23: 222-226, 2005.
22. Kasinski AL and Slack FJ: Epigenetics and genetics. MicroRNAs en route to the clinic: Progress in validating and targeting microRNAs for cancer therapy. Nat Rev Cancer 11:849-864, 2011.
23. Hartung T, Balls M, Bardouille C, Blanck O, Coecke S, Gstraunthaler G and Lewis D: Good Cell Culture Practice. ECVAM Good Cell Culture Practice Task Force Report 1. Altern Lab Anim 30: 407-414, 2002.
24. Kraus B, Boller K, Reuter A and Schnierle BS: Characterization of the human endogenous retrovirus K Gag protein: Identification of protease cleavage sites. Retrovirology 8: 21, 2011.
25. Bieda K, Hoffmann A and Boller K: Phenotypic heterogeneity of human endogenous retrovirus particles produced by teratocarcinoma cell lines. J Gen Virol 82: 591-596, 2001.
26. Maes OC, Sarojini H and Wang E: Stepwise up-regulation of microRNA expression levels from replicating to reversible and irreversible growth arrest states in WI-38 human fibroblasts. J Cell Physiol 221: 109-119, 2009.
27. Kurth R and Bannert N: Beneficial and detrimental effects of human endogenous retroviruses. Int J Cancer 126: 306-314, 2010.
28. Pan J, Hu H, Zhou Z, Sun L, Peng L, Yu L, Sun L, Liu J, Yang Z and Ran Y: Tumor-suppressive mir-663 gene induces mitotic catastrophe growth arrest in human gastric cancer cells. Oncol Rep 24: 105-112, 2010.
29. Yi C, Wang Q, Wang L, Huang Y, Li L, Liu L, Zhou X, Xie G, Kang T, Wang H, Zeng M, Ma J, Zeng Y and Yun JP: MiR-663, a microRNA targeting p21(WAF1/CIP1), promotes the proliferation and tumorigenesis of nasopharyngeal carcinoma. Oncogene 2012. Jan 16. doi: 10.1038/onc.2011.629.
30. Marques FZ, Campain AE, Tomaszewski M, Zukowska-Szczechowska E, Yang YH, Charchar FJ and Morris BJ: Gene expression profiling reveals renin mRNA overexpression in human hypertensive kidneys and a role for microRNAs. Hypertension 58: 1093-1098, 2011.
31. Lu J, Kwan BC, Lai FM, Tam LS, Li EK, Chow KM, Wang G, Li PK and Szeto CC: Glomerular and tubulointerstitial miR-638, miR-198 and miR-146a expression in lupus nephritis. Nephrology (Carlton) 17: 346-351, 2012.
32. Liang P, Lv C, Jiang B, Long X, Zhang P, Zhang M, Xie T and Huang X: MicroRNA profiling in denatured dermis of deep burn patients. Burns 38: 534-540, 2012.
33. Te JL, Dozmorov IM, Guthridge JM, Nguyen KL, Cavett JW, Kelly JA, Bruner GR, Harley JB and Ojwang JO: Identification of unique microRNA signature associated with lupus nephritis. PLoS ONE 5: e10344, 2010.
34. Ehlhardt S, Seifert M, Schneider J, Ojak A, Zang KD and Mehraein Y: Human endogenous retrovirus HERV-K(HML-2) Rec expression and transcriptional activities in normal and rheumatoid arthritis synovia. J Rheumatol 33: 16-23, 2006.
35. Antony JM, Deslauriers AM, Bhat RK, Ellestad KK and Power C: Human endogenous retroviruses and multiple sclerosis: innocent bystanders or disease determinants? Biochim Biophys Acta 1812: 162-176, 2011.
36. Yang Y, Wang LL, Li YH, Gao XN, Liu Y and Yu L: Effect of CpG island methylation on microRNA expression in the k-562 cell line. Biochem Genet 50: 122-134, 2012.
37. Stengel S, Fiebig U, Kurth R and Denner J: Regulation of human endogenous retrovirus-K expression in melanomas by CpG methylation. Genes Chromosomes Cancer 49: 401-411, 2010.
38. Iramaneerat K, Rattanatunyong P, Khemapech N, Triratanachat S and Mutirangura A: HERV-K hypomethylation in ovarian clear cell carcinoma is associated with a poor prognosis and platinum resistance. Int J Gynecol Cancer 21: 51-57, 2011.
39. Metias SM, Lianidou E and Yousef GM: MicroRNAs in clinical oncology: at the crossroads between promises and problems. J Clin Pathol 62: 771-776, 2009.
40. Wittmann J and Jack HM: Serum microRNAs as powerful cancer biomarkers. Biochim Biophys Acta 1806: 200-207, 2010.